Carlos V Paya
CIK 1606244 · President and CEO · last filed 2026-05-18
Carlos V Paya is a President and CEO who has filed 38 SEC Form 4 insider transactions across 5 companies since 2017. The most recent filing, for COLL, was dated May 18, 2026. Across all open-market trades the lifetime net is −$6.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.58M
5
38
-$6.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COLL | Director | 28,323 | $34.64 | $981.1K | $0 | 2 | 2026-05-18 |
| PCVX | Director | 10,216 | $47.46 | $484.9K | $0 | 7 | 2025-06-16 |
| LAB | Director | 126,844 | $0.89 | $112.6K | $0 | 2 | 2023-06-16 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 69,554 | $3.71 | $258.0K | $0 | 16 | 2021-05-27 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 0 | $0.34 | $0 | -$6.7K | 3 | 2021-03-16 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | COLL | Grant (A) | +8,741 | $0 | EDGAR |
| 2025-06-16 | PCVX | Grant (A) | +3,041 | $0 | EDGAR |
| 2025-05-19 | COLL | Grant (A) | +19,582 | $0 | EDGAR |
| 2024-12-10 | PCVX | Mixed | — | $0 | EDGAR |
| 2024-06-10 | PCVX | Grant (A) | +1,550 | $0 | EDGAR |
| 2023-11-09 | PCVX | Mixed | — | $0 | EDGAR |
| 2023-06-16 | LAB | Grant (A) | +26,376 | $0 | EDGAR |
| 2023-06-15 | PCVX | Grant (A) | +2,500 | $0 | EDGAR |
| 2022-06-17 | LAB | Grant (A) | +30,914 | $0 | EDGAR |
| 2022-06-03 | PCVX | Grant (A) | +3,125 | $0 | EDGAR |